BC Cancer trainee Gillian Carleton receives prestigious Vanier scholarship

Gillian Carleton is no stranger to hard work. The BC Cancer researcher, University of Victoria student and Team Canada Olympic medalist can now include a Vanier Canada Scholarship award under their belt. The award is arguably one of the most prestigious graduate scholarship awards in Canada, offering recipients $50,000 per year for 3 years while they finish their graduate studies.

A new combination treatment targeting “cancer stem cells” may overcome drug resistance in blood cancers

Building on a BC Cancer discovery from decades past, a new combination treatment has shown promise to overcome drug resistance and relapse in people with chronic myeloid leukemia. 

Building off the discovery of an enzyme called integrin-linked kinase (ILK) made by BC Cancer distinguished scientist Dr. Shoukat Dedhar 24 years ago, BC Cancer’s Drs. Xiaoyan Jiang and Shoukat Dedhar have made a significant advancement in understanding the role of this enzyme in blood cancers. 

Back to top